EU agencies gearing up for larger post-Brexit role

Despite UK parliamentarians voting 305-301 in favor of continued involvement with the European Medicines Agency (EMA), medicines regulators across Europe are stepping up efforts in preparation for a possible ‘no-deal’ Brexit.

European Union country agencies are hiring extra staff and taking on more work as the UK’s Medicines and Healthcare products Regulatory Agency (MRHA) winds down its share of the EU’s regulatory work.

As a result of the UK’s decision to leave the EU, the EMA is being relocated to Amsterdam, from its current headquarters in London.